MAY - 2023LIFE SCIENCES REVIEW4From ideation to portfolio program: Innovation vs validation in early drug discoveryCarlos Pedraza, Ph.D., Director of CNS Biology, Alkermes08IN MY OPINIONLAST WORD30C O VER S T OR Y12Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson, Senior Director, Chemical Research and Development, Pfizer Inc.DOLORES BAKSH, CEOENZYMATIC DNA: THE NEXT ERA IN GENE THERAPYCONTENTS
< Page 3 | Page 5 >